Dhampur Bio Organics: CARE Ratings Reaffirms 'BBB+' on Long-Term Facilities, Outlook Revised to Positive
Dhampur Bio Organics' long-term bank facilities reaffirmed at CARE BBB+ with outlook revised to Positive by CARE Ratings. Short-term facilities reaffirmed at CARE A2. Debt reduction expected from ₹305 crore sale of Meerganj unit. Profitability to improve due to unit sale and strong sugar prices.
The revision of the outlook to positive and reaffirmation of credit ratings are significant for the company's borrowing costs and investor confidence, impacting its financial strategy and operational flexibility.
The credit rating has been reaffirmed with a positive outlook, indicating an improved financial risk profile and expected better profitability for the company.
Dhampur Bio Organics Limited (DBOL) has received a credit rating reaffirmation from CARE Ratings Limited. The long-term bank facilities, amounting to ₹987.05 crore (reduced from ₹1,019.45 crore), have been reaffirmed at 'CARE BBB+' with the outlook revised from 'Stable' to 'Positive'. The short-term bank facilities of ₹75.00 crore (reduced from ₹115.00 crore) were also reaffirmed at 'CARE A2'.
The revision in outlook reflects an anticipated improvement in DBOL's financial risk profile, primarily driven by debt reduction through the pre-payment of long-term loans. This was aided by cash flows generated from the slump sale of its sugar unit in Meerganj in June 2026 for ₹305 crore. While this sale is expected to reduce the company's scale, it is also projected to improve profitability as the Meerganj unit was adversely affected by red-rot infestation and impacted overall operating efficiency.
CARE Ratings notes the company's initiatives to adopt newer cane varieties to reduce infestation and improve yields, alongside strong prevailing sugar prices and a focus on ethanol production. These factors are expected to support profitability in the medium term. However, potential increases in UP-state advised prices (SAP) and strengthening El Niño conditions remain monitorable. The ratings continue to benefit from experienced promoters, long track record in the sugar industry, and forward-integrated operations including distillery and cogeneration. Conversely, constraints include the industry's cyclical and regulated nature, demand-supply dynamics, agro-climatic risks, and working capital-intensive operations.
The company has already paid off ₹165 crore from the Meerganj unit sale proceeds between April and July 2026, reducing its long-term debt. Further payments are expected, leading to a projected reduction in net leverage to below 5.5x by the end of FY27. Interest coverage is also expected to improve. The company's liquidity is considered adequate, supported by expected gross cash accruals and available credit lines.
What to do with a filing like this
Dhampur Bio Organics Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dhampur Bio Organics Limited. Read the original for the full detail.